Publication | Open Access
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
2K
Citations
23
References
2002
Year
Imatinib induced high rates of cytogenetic and hematologic responses in patients with chronic-phase CML in whom previous interferon therapy had failed.
| Year | Citations | |
|---|---|---|
Page 1
Page 1